Money for Medication: A randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with a psychotic disorder and co-morbid substance abuse.
- Conditions
- Outpatients with psychotic disorders and comorbid substance abuse having an indication for antipsychotic depot medication
- Registration Number
- NL-OMON28385
- Lead Sponsor
- Centrum Dubbele Problematiek (CDP), PalierAvocadostraat 332552 HS Den HaagTelefoon: 070-391 76 11b.vanderhoorn@palier.nl
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 168
Inclusion Criteria
1. Age between 18 and 65 years;
2. Psychotic disorder (including schizophrenia, schizoaffective disorder or other psychotic disorders);
Exclusion Criteria
1. Not meeting all inclusion criteria;
2. Inability to participate in this study due to cognitive impairments;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number (percentage) of accepted depot injections.
- Secondary Outcome Measures
Name Time Method 1. Longest uninterrupted period of depot medication acceptance;<br /><br>2. Time expired before depot is taken;<br /><br>3. Effort initiated by clinicians to provide depot;<br /><br>4. Psychiatric symptomatology (PANSS);<br /><br>5. Health, psychological and social functioning (HoNOS);<br /><br>6. Substance use (ASI, Section III, CIDI-SAM, verified by urine-analysis);<br /><br>7. Subjective Quality of Life (MANSA);<br /><br>8. Antipsychotic Side-effects (ASC);<br /><br>9. Cost Utility (TiC-P, EQ-5D);<br /><br>10. Impulsivity (DII);<br /><br>11. Attitudes towards medication (ROMI);<br /><br>12. Attitudes towards M4M.